1. product development research on low-cost RTI diagnostics, therapeutics, vaccines, and woman-controlled prevention technologies, such as vaginal microbicides; and

  2. documentation of the interactions of RTIs and existing contraceptive technology.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement